Medical News

RSS

Child abuse prevention programs promised by the Coalition

The Coalition has promised an expenditure of $50.5 million to take on child abuse in Victoria, if it wins next month's election. The claims made say that the aim would be to try for early intervention, aimed at reducing the rates of abuse.

26 Oct 2010

Glaxo to pay $750 million in defective drug settlement

GlaxoSmithKline Plc, one of the world’s largest pharmaceutical companies, has agreed to pay $750 million to settle a U.S. government false-claims lawsuit over the sale of defective drugs. The lawsuit first filed in 2004 by Cheryl D. Eckard, a former global quality assurance manager for the London-based company came to a settlement finally. Eckard, 51, said, “This is not something I wanted to do, but because of patient safety it was necessary.” Being the one to bring this to notice she would receive $96 million from the settlement money. She had warned the company earlier but was fired because of her efforts.

26 Oct 2010

Onlife relocates to larger 55,000-square-foot space in Brentwood

Personal health coaching company Onlife Health, Inc. has moved into new offices specifically designed to foster positive living and workplace wellness among the company's employees. Onlife consolidated its three separate offices into one larger 55,000-square-foot space when it relocated to the Horizon Center in Brentwood, Tenn., this month, giving the company more capacity for continued growth.

26 Oct 2010

PinPointe FootLaser receives FDA clearance for treatment of nail fungus

The podiatry practice of Mark E. Spier, DPM, announced today that the PinPointe™ FootLaser™ has received clearance from the U.S. Food and Drug Administration (FDA) for the treatment of nail fungus (onychomycosis). Dr. Spier is the first certified provider of the treatment in the Baltimore area.

26 Oct 2010

Medicare reimbursement changes increase demand for intermittent catheters

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, reimbursement changes have caused the demand for intermittent catheters to increase significantly. In April 2008, Medicare changed reimbursement to cover up to 200 catheters per month, instead of the previous 4 that it covered.

26 Oct 2010

PPD and VirtualScopics partner to provide medical imaging services

PPD, Inc. and VirtualScopics, Inc. today announced a strategic alliance to deliver a comprehensive set of clinical and medical imaging services that will enable biopharmaceutical companies to make faster, more confident decisions on the development of their oncology compounds, creating time and cost efficiencies.

26 Oct 2010

Decision Resources moves global corporate headquarters to larger space in Burlington

Decision Resources, Inc., one of the world's leading research and advisory firms focusing on healthcare insights and analysis, has moved its global corporate headquarters from Waltham, MA to Burlington, MA. The significantly larger office space located at 8 New England Executive Park in Burlington, MA allows the Company to plan for future growth.

26 Oct 2010

Keryx completes randomization of last patient in Zerenex Phase 3 study for hyperphosphatemia

Keryx Biopharmaceuticals reported today the randomization of the last patient in its short-term study component of its Phase 3 registration program of Zerenex™ (ferric citrate), the Company's iron-based phosphate binder for the treatment of elevated serum phosphorous levels, or hyperphosphatemia, in patients with end-stage renal disease on dialysis.

26 Oct 2010

Aastrom Biosciences and ATEK Medical enter new strategic partnership

Aastrom Biosciences, Inc., a leading developer of expanded autologous cellular therapies for the treatment of severe cardiovascular diseases, and ATEK Medical, a leading medical device manufacturer, today announced the formation of a new strategic partnership in which ATEK Medical will supply key components and technology for use in Aastrom's proprietary cell manufacturing process.

26 Oct 2010

Strativa enters amended agreement with Sobi for Nascobal Vitamin B12 Nasal Spray

Strativa Pharmaceuticals today announced that it has entered into an amended and restated license and supply agreement with Swedish Orphan Biovitrum (Sobi) covering the European development and commercialization rights of Strativa's Nascobal (cyanocobalamin) Vitamin B12 Nasal Spray. Strativa acquired the worldwide rights to Nascobal from QOL Medical, LLC in March 2009, which included a pre-existing agreement with Sobi.

26 Oct 2010

Cynosure third quarter net loss decreases to $0.5 million

Cynosure, Inc. today announced financial results for the three months ended September 30, 2010.

26 Oct 2010

Caldera Medical relocates to new, larger facility

Caldera Medical today announced its relocation to a new facility in Agoura Hills, CA. The former corporate headquarters of DTS offers Caldera approximately eight times more square footage in anticipation of continued growth as well as capability expansion.

26 Oct 2010

MDS to change name to Nordion effective November 1, 2010

MDS Inc., a leading provider of products and services to the global health science market, today announced it will be formally changing its name to Nordion Inc., effective November 1, 2010.

26 Oct 2010

Purdue and Mundipharma assume worldwide development for Infinity's fatty acid amide hydrolase program

Infinity Pharmaceuticals, Inc. today announced that Purdue Pharmaceutical Products L.P. and its independent associated company, Mundipharma International Corporation Ltd., have exercised their right to assume worldwide development and commercialization activities for Infinity's fatty acid amide hydrolase, or FAAH, program. The decision reflects progress made in the development of Infinity's oral FAAH inhibitor, IPI-940.

26 Oct 2010

miRagen and CU enter agreement on miRNA therapeutics discovery and development

miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, and the University of Colorado (CU) announced today that they have entered into sponsored research and licensing agreements to collaborate on miRNA therapeutics discovery and development.

26 Oct 2010

Agile presents AG200-15 contraceptive patch Phase 2 clinical study results at 66th ASRM

Agile Therapeutics announced results today from a Phase 2 clinical study of AG200-15, Agile's weekly contraceptive patch containing ethinyl estradiol (EE) in combination with levonorgestrel (LNG). According to the clinical findings, AG200-15 provides a low daily dose of estrogen equivalent to 30 micrograms EE, similar to that in low-dose, oral contraceptive (OC) pills.

26 Oct 2010

ACS My Medicare Advocate helps retirees chart Medicare decision process

Retirees will find it easier than ever to navigate the often confusing maze of Medicare enrollment with the introduction of My Medicare Advocate by Affiliated Computer Services, Inc., A Xerox Company.

26 Oct 2010

Mundus studies potential for VTOL UAV against Malaria

Mundus Group Inc., studies potential for VTOL UAV to provide increased capabilities in fight against Malaria and disease spread through mosquitoes with precision aerial laser eradication treatments.

26 Oct 2010

Cryo-Cell formalizes industry-exclusive agreement with MedTech For Solutions GPO

Cryo-Cell International, Inc., one of the world's largest and most established family cord blood banks and global stem cell innovators, today announced at the annual meeting of the American Society of Reproductive Medicine (ASRM) that the Company has formalized an industry-exclusive agreement with MedTech For Solutions, Inc., a Group Purchasing Organization (GPO) representing a member network of 115 practices specializing in reproductive medicine, which operates in conjunction with The Broadlane Group.

26 Oct 2010

New heart and vascular clinic to implement Streamline Health's HIM Suite of document workflow solutions

Streamline Health Solutions, Inc. a leading provider of document workflow solutions for hospitals, today announced that one of the country's leading healthcare organizations expects to open a new facility utilizing Streamline Health's Suite of Health Information Management document workflow solutions.

26 Oct 2010

Medical News

Child abuse prevention programs promised by the Coalition

Glaxo to pay $750 million in defective drug settlement

Onlife relocates to larger 55,000-square-foot space in Brentwood

PinPointe FootLaser receives FDA clearance for treatment of nail fungus

Medicare reimbursement changes increase demand for intermittent catheters

PPD and VirtualScopics partner to provide medical imaging services

Decision Resources moves global corporate headquarters to larger space in Burlington

Keryx completes randomization of last patient in Zerenex Phase 3 study for hyperphosphatemia

Aastrom Biosciences and ATEK Medical enter new strategic partnership

Strativa enters amended agreement with Sobi for Nascobal Vitamin B12 Nasal Spray

Cynosure third quarter net loss decreases to $0.5 million

Caldera Medical relocates to new, larger facility

MDS to change name to Nordion effective November 1, 2010

Purdue and Mundipharma assume worldwide development for Infinity's fatty acid amide hydrolase program

miRagen and CU enter agreement on miRNA therapeutics discovery and development

Agile presents AG200-15 contraceptive patch Phase 2 clinical study results at 66th ASRM

ACS My Medicare Advocate helps retirees chart Medicare decision process

Mundus studies potential for VTOL UAV against Malaria

Cryo-Cell formalizes industry-exclusive agreement with MedTech For Solutions GPO

New heart and vascular clinic to implement Streamline Health's HIM Suite of document workflow solutions

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News